[1]高 彬,孙 娜,常文秀.慢性肾脏病患者血钾异常相关因素分析[J].医学信息,2019,32(22):91-93.[doi:10.3969/j.issn.1006-1959.2019.22.027]
　GAO Bin,SUN Na,CHANG Wen-xiu.Analysis of Related Factors of Serum Potassium Abnormality in Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(22):91-93.[doi:10.3969/j.issn.1006-1959.2019.22.027]
点击复制

慢性肾脏病患者血钾异常相关因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
91-93
栏目:
临床研究
出版日期:
2019-11-15

文章信息/Info

Title:
Analysis of Related Factors of Serum Potassium Abnormality in Patients with Chronic Kidney Disease
文章编号:
1006-1959（2019）22-0091-03
作者:
高 彬; 孙 娜; 常文秀
（天津市第一中心医院肾病科，天津 300072）
Author(s):
GAO Bin; SUN Na; CHANG Wen-xiu
(Department of Nephrology,Tianjin First Central Hospital,Tianjin 300072,China)
关键词:
慢性肾脏病; 低钾血症; 高钾血症; 肾小球滤过率
Keywords:
Chronic kidney disease; Hypokalemia; Hyperkalemia; Glomerular filtration rate
分类号:
R692
DOI:
10.3969/j.issn.1006-1959.2019.22.027
文献标志码:
A
摘要:
目的 分析慢性肾脏病患者（CKD）血钾异常的临床特点及其影响因素。方法 选取2014年12月~2018年12月我院诊治的321例慢性肾脏病患者，记录患者性别、年龄、是否服用利尿剂、是否合并高血压、肾小球滤过率（eGFR）、血肌酐（Scr)、尿素氮（BUN）、二氧化碳（CO2）水平，观察慢性肾脏病患者血清钾的异常发生率，比较不同CKD分期（CKD1~5期）患者的血钾水平、不同血钾水平患者性别、年龄、是否服用利尿剂、是否合并高血压、eGFR、Scr、BUN、CO2等差异及其与血钾的相关性。结果 321例CKD患者中血钾异常36例，血钾异常发生率为11.21%。其中低钾血症19例、血钾正常患者285例、高钾血症17例；CKD1~2期156例，CKD3a期43例，CKD3b期40例，CKD 4~5期82例；CKD早期患者与CKD晚期患者血钾水平比较，差异有统计学意义（P＜0.05）；高钾血症患者高血压所占比例、eGFR、BUN、Scr水平高于血钾正常及低钾血症患者，差异有统计学意义（P＜0.05）；高钾血症患者血清CO2、服用利尿剂比例低于血钾正常及低钾血症患者，差异有统计学意义（P＜0.05）；不同血钾水平患者年龄、性别比较，差异无统计学意义（P＞0.05）；Logistic回归分析显示，血清钾水平与是否服用利尿剂、BUN、Scr呈正相关（P＜0.05），与血清CO2、eGFR呈负相关（P＜0.05）。结论 慢性肾脏病患者血钾水平随CKD分期的进展逐期升高，服用利尿剂、BUN和Scr升高，eGFR和CO2水平降低的患者更容易发生高血钾症，临床应加强对患者肾功能指标的监测，有效控制血钾异常危险因素。
Abstract:
Objective To analyze the clinical features and influencing factors of serum potassium abnormalities in patients with chronic kidney disease (CKD). Methods A total of 321 patients with chronic kidney disease who were treated in our hospital from December 2014 to December 2018 were enrolled. The patient's gender, age, diuretics, hypertension, glomerular filtration rate (eGFR), serum creatinine were recorded (Scr), urea nitrogen (BUN), carbon dioxide (CO2) levels, observe the abnormal incidence of serum potassium in patients with chronic kidney disease, compare the blood potassium levels of patients with different CKD stages (CKD1~5), gender of different blood potassium levels , age, whether taking diuretics, whether combined with hypertension, eGFR, Scr, BUN, CO2 and other differences and their correlation with serum potassium. Results Of the 321 patients with CKD, 36 had abnormal potassium levels, and the incidence of abnormal potassium was 11.21%. There were 19 cases of hypokalemia, 285 cases of normal potassium and 17 cases of hyperkalemia; 156 cases of CKD1~2, 43 cases of CKD3a, 40 cases of CKD3b, 82 cases of CKD 4~5; early stage of CKD Compared with serum potassium levels in patients with advanced CKD, the difference was statistically significant (P<0.05). The proportion of hypertension, eGFR, BUN and Scr in patients with hyperkalemia were higher than those in patients with normal potassium and hypokalemia,the difference was statistically significant (P<0.05). The serum CO2 and diuretic ratio of patients with hyperkalemia were lower than those with normal potassium and hypokalemia, the difference was statistically significant (P<0.05); different potassium levels There was no significant difference in age and gender between the patients (P>0.05). Logistic regression analysis showed that serum potassium levels were positively correlated with diuretics, BUN and Scr (P<0.05), and negatively correlated with serum CO2 and eGFR(P<0.05).Conclusion The serum potassium level of patients with chronic kidney disease increases with the progression of CKD stage. The patients taking diuretics, BUN and Scr are elevated, and patients with decreased eGFR and CO2 levels are more likely to have hyperkalemia. The clinical function of patients should be strengthened. The monitoring of indicators effectively controls the risk factors of abnormal blood potassium.

参考文献/References:

[1]Jesse TT.Hypokalemia and Hyperkalemia[J].Hospital Medicine Clinics,2015,4(1):34-50. [2]刘迅,吕凛生,唐骅,等.慢性肾脏病不同分期血钾变化及影响因素分析[J].中华全科医学,2010,8(7):817-818. [3]刘迅,王成,唐骅,等.慢性肾脏病不同分期血二氧化碳结合力的变化及其影响因素分析[J].中国中西医结合肾病杂志,2009,10(5):419-421. [4]丁延辉,丁俊丽,周青,等.全反式维甲酸对实验性动脉粥样硬化兔动脉血管内皮依赖性舒张功能的影响[J].安徽医科大学学报,2017,52(1):7-12. [5]刘红,孙伟,顾刘宝,等.黄芪治疗慢性肾脏病机制及其延缓细胞衰老研究[J].中华肾病研究电子杂志,2014,3(6):40-43. [6]杨红,张波.慢性肾功能衰竭患者高钾血症48 例临床观察[J].首都医药,2016,6(16):38. [7]林夏阳.慢性肾功能衰竭合并高钾血症的临床分析[J].临床合理用药,2015,2(17):54. [8]Muschart X,Boulouffe C,Jamart J,et al.A determination of the current causes of hyperkalaemia and whether they have changed over the past 25 years[J].Acta clinica Belgica,2014,69(4):280-284. [9]吴建跃,王卫民,肖国民,等.低钾血症对颅脑创伤患者预后的影响[J].浙江医学,2015(3):211-215.

相似文献/References:

[1]谢 琴.肾小球C4d沉积在慢性肾病早期诊断及预后的价值分析[J].医学信息,2018,31(08):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
　XIE Qin.Value of Glomerular C4d Deposition in Early Diagnosis and Prognosis of Chronic Kidney Disease[J].Journal of Medical Information,2018,31(22):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
[2]钟 旭.慢性肾脏病相关神经精神疾病的研究[J].医学信息,2022,35(11):51.[doi:10.3969/j.issn.1006-1959.2022.11.015]
　ZHONG Xu.Study on Neuropsychiatric Diseases Associated with Chronic Kidney Disease[J].Journal of Medical Information,2022,35(22):51.[doi:10.3969/j.issn.1006-1959.2022.11.015]
[3]林萃才.潮州市人民医院登革热患者年龄分布及临床检验分析[J].医学信息,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.18.027]
　LIN Cui-cai.Analysis of Age Distribution and Clinical Examination of Dengue Fever Patients in Chaozhou People's Hospital[J].Journal of Medical Information,2018,31(22):88.[doi:10.3969/j.issn.1006-1959.2018.18.027]
[4]彭琪彦.慢性肾脏病患者RBP与T淋巴细胞亚群 检测的临床意义[J].医学信息,2019,32(18):91.[doi:10.3969/j.issn.1006-1959.2019.18.029]
　PENG Qi-yan.Clinical Significance of Detection of RBP and T Lymphocyte Subsets in Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(22):91.[doi:10.3969/j.issn.1006-1959.2019.18.029]
[5]徐海红,刘 宇,宋桂云.腹膜透析患者认知功能障碍对日常透析操作影响的研究[J].医学信息,2022,35(15):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
　XU Hai-hong,LIU Yu,SONG Gui-yun.Study on the Effect of Cognitive Dysfunction in Peritoneal Dialysis Patients on Daily Dialysis Operation[J].Journal of Medical Information,2022,35(22):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
[6]崔方强.足细胞上皮间质转分化研究[J].医学信息,2019,32(22):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
　CUI Fang-qiang.Epithelial Transdifferentiation of Podocytes[J].Journal of Medical Information,2019,32(22):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
[7]王希敏.2型糖尿病并发慢性肾脏病患者外周血T淋巴细胞亚群变化与肾血管内皮功能障碍的相关 分析[J].医学信息,2021,34(23):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
　WANG Xi-min.Correlation Analysis of T Lymphocyte Subsets in Peripheral Blood with Renal Vascular Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus Complicated with Chronic Kidney Disease[J].Journal of Medical Information,2021,34(22):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
[8]袁 娟,赫英龙.参芎葡萄糖与前列地尔治疗慢性肾脏病的疗效比较[J].医学信息,2020,33(14):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
　YUAN Juan,HE Ying-long.Comparison of Curative Effect between Shenqiong Glucose and Alprostadil in Treating Chronic Kidney Disease[J].Journal of Medical Information,2020,33(22):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
[9]倪 曼.非布司他与别嘌醇治疗慢性肾脏病合并高尿酸血症的疗效比较[J].医学信息,2020,33(15):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]
　NI Man.Comparison of the Efficacy of Febuxostat Tablets and Allopurinol in the Treatment of Chronic Kidney Disease with Hyperuricemia[J].Journal of Medical Information,2020,33(22):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]
[10]郭 航,潘从清.铁死亡在慢性肾脏病中的研究进展[J].医学信息,2023,36(07):162.[doi:10.3969/j.issn.1006-1959.2023.07.033]
　GUO Hang,PAN Cong-qing.Research Progress of Ferroptosis in Chronic Kidney Disease[J].Journal of Medical Information,2023,36(22):162.[doi:10.3969/j.issn.1006-1959.2023.07.033]

更新日期/Last Update: 2019-11-15